-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics Q4 Earnings Assessment

Benzinga·03/04/2026 21:08:04
Listen to the news

Aquestive Therapeutics (NASDAQ:AQST) announced its Q4 earnings on Wednesday, March 4, 2026 at 04:01 PM.

Here's a breakdown of the earnings report.

Earnings

Aquestive Therapeutics missed estimated earnings by -25.0%, reporting an EPS of $-0.15 versus an estimate of $-0.12.

Revenue was up $1.15 million from the same period last year.

Performance in Previous Earnings

In the previous quarter, the company missed on EPS by $0.02, resulting in a 2.17% increase change in the share price the following day.

Here's a look at Aquestive Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.12 -0.18 -0.16 -0.13
EPS Actual -0.14 -0.14 -0.24 -0.19
Revenue Estimate 13.11M 11.22M 12.23M 13.11M
Revenue Actual 12.81M 10.00M 8.72M 11.87M

To track all earnings releases for Aquestive Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.